Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Tudor Pickering Downgrades Ford Motor to Hold

Tudor Pickering Downgrades Ford Motor to Hold

Tudor Pickering analyst Jeoffrey Lambujon downgrades Ford Motor (NYSE:F) from Buy to Hold.

byBenzinga Newsdesk

February 15, 2023

1 minute read

Tudor Pickering analyst Jeoffrey Lambujon downgrades Ford Motor (NYSE:F) from Buy to Hold.

Oil Giant Chevron’s Golden State Setback: To Incur Up To $4B Charge in Q4 Over California Challenges

By Shivani Kumaresan

January 2, 10:06 AM

Oil major Chevron Corporation (NYSE: CVX) will be impairing a portion of its U.S. upstream assets, primarily in California, in the fourth quarter of FY23.

CVX

News

Analyst Ming-Chi Kuo Says Apple Likely To Build New Apple Car Project Team Before End Of Year

By Benzinga Newsdesk

September 28, 1:36 PM

- Reuters

AAPL

AmerisourceBergen Boosts FY22 Profit Outlook As Q3 Beat Expectations

By Vandana Singh

August 3, 12:00 PM

AmerisourceBergen Corp’s (NYSE:ABC) Q3 FY22 adjusted EPS reached $2.62, up 21.3% Y/Y, beating the consensus of $2.57. Revenue of $60.1…

ABC

News

Cellectar Biosciences Granted U.S. Patent #11,439,709 Phospholipid Ether Analogs as Cancer-targeting Drug Vehicles

By Charles Gross

September 13, 9:36 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6652&f=G&l=50&d=PTXT&p=134&S1=20220913&OS=20220913&RS=20220913

CLRB

Tudor Pickering Downgrades Ford Motor to Hold

Related Posts

Oil Giant Chevron’s Golden State Setback: To Incur Up To $4B Charge in Q4 Over California Challenges

Analyst Ming-Chi Kuo Says Apple Likely To Build New Apple Car Project Team Before End Of Year

AmerisourceBergen Boosts FY22 Profit Outlook As Q3 Beat Expectations

Cellectar Biosciences Granted U.S. Patent #11,439,709 Phospholipid Ether Analogs as Cancer-targeting Drug Vehicles